Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity
出版年份 2022 全文链接
标题
Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity
作者
关键词
-
出版物
CLINICAL NUTRITION
Volume 41, Issue 9, Pages 1969-1976
出版商
Elsevier BV
发表日期
2022-07-19
DOI
10.1016/j.clnu.2022.07.001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial
- (2022) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward‐ and attention‐related brain centres in response to visual food cues in adults with obesity: A cross‐sectional functional MRI study
- (2021) Nikolaos Perakakis et al. DIABETES OBESITY & METABOLISM
- Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis
- (2021) Nikolaos Perakakis et al. LIVER INTERNATIONAL
- The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective
- (2021) J. Michael Conlon Frontiers in Endocrinology
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of glicentin and oxyntomodulin in human metabolism: new evidence and new directions
- (2020) Nikolaos Perakakis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acute Effects of Three Different Meal Patterns on Postprandial Metabolism in Older Individuals with a Risk Phenotype for Cardiometabolic Diseases: A Randomized Controlled Crossover Trial
- (2020) Yannik B. Schönknecht et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Effect of the glucagon‐like peptide‐1 analogue liraglutide versus placebo treatment on circulating proglucagon‐derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial
- (2020) Sun H. Kim et al. DIABETES OBESITY & METABOLISM
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study
- (2019) Preeshila Behary et al. DIABETES CARE
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Methods and Guidelines for Measurement of Glucagon in Plasma
- (2019) Jens J. Holst et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD
- (2019) Stergios A Polyzos et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
- (2019) Alexander Kokkinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity
- (2019) Victoria Higgins et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials
- (2019) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacotherapy of type 2 diabetes: An update
- (2018) Jagriti Upadhyay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Reduced GLP-1 Secretion at 30 Minutes After a 75g Oral Glucose Load is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study
- (2018) Nithya Sukumar et al. DIABETES
- Follistatins in glucose regulation in healthy and obese individuals
- (2018) Nikolaos Perakakis et al. DIABETES OBESITY & METABOLISM
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon action in the brain
- (2016) Mona A. Abraham et al. DIABETOLOGIA
- Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis
- (2016) Maria T. Vamvini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
- (2016) Hannes Manell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma
- (2016) Nicolai J. Wewer Albrechtsen et al. EBioMedicine
- Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
- (2016) Niina Matikainen et al. PLoS One
- GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
- (2015) Kristine Færch et al. DIABETES
- Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure
- (2015) Jonatan Ising Bagger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 Responses Are Heritable and Blunted in Acquired Obesity With High Liver Fat and Insulin Resistance
- (2013) Niina Matikainen et al. DIABETES CARE
- Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
- (2013) S. Calanna et al. DIABETOLOGIA
- Gender and body mass index modify the effect of increasing amounts of caffeinated coffee on postprandial glucose and insulin concentrations; a randomized, controlled, clinical trial
- (2013) Anna Gavrieli et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals
- (2013) A. Gavrieli et al. Obesity
- Incretin Hormone and Insulin Responses to OralVersusIntravenous Lipid Administration in Humans
- (2011) Ola Lindgren et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
- (2011) Jonatan I. Bagger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rise of Oxyntomodulin in Response to Oral Glucose after Gastric Bypass Surgery in Patients with Type 2 Diabetes
- (2010) Blandine Laferrère et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Incretin and islet hormonal responses to fat and protein ingestion in healthy men
- (2008) Richard D. Carr et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started